Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
RA patients exhibited significantly higher inflammatory and metabolic burden, markedly poorer sleep quality, and lower Vitamin D levels than controls (all p < 0.001).
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cross-sectional study.
Cross-sectional study
Examines a population at a particular point in time.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
In this cross-sectional study, 128 patients with RA and 115 healthy controls were evaluated.
Source: Abstract.
Between January 2024 and October 2025, 1,800 patients were initially screened.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
The mediating role of sleep quality in the association between inflammatory disease activity and health-related quality of life in rheumatoid arthritis
Cross-sectional study · Frontiers in Medicine · 2026
Original publication title
The mediating role of sleep quality in the association between inflammatory disease activity and health-related quality of life in rheumatoid arthritis
Copyright © 2026 Akar, Yıldırım, Karakoyun, Kaya, Batmaz, Em and Karakoç.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Sleep disturbance is highly prevalent in rheumatoid arthritis (RA) and is a key determinant of patient-reported outcomes. However, the mechanistic pathways linking systemic inflammation and metabolic dysregulation, defined in this study as insulin resistance and adverse cardiometabolic indices, and sleep quality remain poorly defined. This study aimed to investigate the interplay between inflammatory/metabolic markers and sleep quality, and to determine whether sleep quality mediates the relationship between disease activity by DAS28-ESR and health-related quality of life.
Source: BackgroundAbstract: What methods does the paper describe?
In this cross-sectional study, 128 patients with RA and 115 healthy controls were evaluated. Systemic inflammation and metabolic stress were characterized using ESR, CRP, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and indices including the TyG index and cardiometabolic index. Sleep was assessed via the Pittsburgh Sleep Quality Index and HRQoL via the Short Form-36. Mediation analyses (5,000 bootstrap resamples), adjusted for age, sex, smoking status, education level, and disease duration, and sensitivity analyses were performed to quantify the indirect effects of sleep quality on HRQoL domains.
Source: MethodsAbstract: Results
RA patients exhibited significantly higher inflammatory and metabolic burden, markedly poorer sleep quality, and lower Vitamin D levels than controls (all p < 0.001). DAS28-ESR was the strongest independent predictor of poor sleep (β = 0.534, p < 0.001), while Vitamin D was an independent predictor of better sleep (β = −0.173, p = 0.002). Mediation analyses revealed that sleep quality may significantly mediate the association between disease activity and life quality, accounting for 24.4% of the effect of DAS28-ESR on Mental Health (Indirect Effect = −1.42; 95% CI − 2.38 to −0.62) and 23.6% on General Health.
Sensitivity analyses confirmed these mediating effects were robust across BMI and gender subgroups.
Source: ResultsAbstract: Conclusion
Sleep quality may represent a critical mechanistic link through which inflammatory disease activity translates into impaired HRQoL in RA. These findings suggest that nearly one-quarter of the disease’s psychological burden may be statistically mediated through sleep disruption. Integrating systematic sleep assessment and Vitamin D optimization into routine care may help mitigate the patient-perceived disease burden. Given the cross-sectional design, these findings should be interpreted as evidence of statistical mediation rather than confirmed causal pathways.
Source: ConclusionAuthors’ abstract
Background
Sleep disturbance is highly prevalent in rheumatoid arthritis (RA) and is a key determinant of patient-reported outcomes. However, the mechanistic pathways linking systemic inflammation and metabolic dysregulation, defined in this study as insulin resistance and adverse cardiometabolic indices, and sleep quality remain poorly defined. This study aimed to investigate the interplay between inflammatory/metabolic markers and sleep quality, and to determine whether sleep quality mediates the relationship between disease activity by DAS28-ESR and health-related quality of life.
Methods
In this cross-sectional study, 128 patients with RA and 115 healthy controls were evaluated. Systemic inflammation and metabolic stress were characterized using ESR, CRP, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and indices including the TyG index and cardiometabolic index. Sleep was assessed via the Pittsburgh Sleep Quality Index and HRQoL via the Short Form-36. Mediation analyses (5,000 bootstrap resamples), adjusted for age, sex, smoking status, education level, and disease duration, and sensitivity analyses were performed to quantify the indirect effects of sleep quality on HRQoL domains.
Results
RA patients exhibited significantly higher inflammatory and metabolic burden, markedly poorer sleep quality, and lower Vitamin D levels than controls (all p < 0.001). DAS28-ESR was the strongest independent predictor of poor sleep (β = 0.534, p < 0.001), while Vitamin D was an independent predictor of better sleep (β = −0.173, p = 0.002). Mediation analyses revealed that sleep quality may significantly mediate the association between disease activity and life quality, accounting for 24.4% of the effect of DAS28-ESR on Mental Health (Indirect Effect = −1.42; 95% CI − 2.38 to −0.62) and 23.6% on General Health.
Sensitivity analyses confirmed these mediating effects were robust across BMI and gender subgroups.
Conclusion
Sleep quality may represent a critical mechanistic link through which inflammatory disease activity translates into impaired HRQoL in RA. These findings suggest that nearly one-quarter of the disease’s psychological burden may be statistically mediated through sleep disruption. Integrating systematic sleep assessment and Vitamin D optimization into routine care may help mitigate the patient-perceived disease burden. Given the cross-sectional design, these findings should be interpreted as evidence of statistical mediation rather than confirmed causal pathways.
Publication and source details
Original title: The mediating role of sleep quality in the association between inflammatory disease activity and health-related quality of life in rheumatoid arthritis
Zeynel Abidin Akar; Dilan Yıldırım; Ömer Karakoyun; Kadir Kaya; İbrahim Batmaz; Serda Em; Mehmet Karakoç
Frontiers in Medicine · 2026
* Correspondence: Zeynel Abidin Akar, zeynelabidin_akar@yahoo.comORCID: Zeynel Abidin Akar, orcid.org/0009-0003-2684-165X
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T23:42:31.631543+00:00
DOI: 10.3389/fmed.2026.1797652 · PMC13033770